At the 2024 annual meeting of the International Society for Cell & Gene Therapy (ISCT) in Vancouver, Canada, Hélio Tomás, PhD, senior research associate at the Instituto de Biologia Experimental e ...

CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.

Engineers have developed a novel method for manufacturing CAR T cells, one that takes just 24 hours and requires only one step, thanks to the use of lipid nanoparticles (LNPs), the potent delivery ...

Peter Maag, PhD, CEO of Kyverna Therapeutics, recalls when people said biologics such as monoclonal antibodies would never work for mass-market applications. “People said that [biologics] are too ...